Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis

Journal of Cellular Biochemistry

Volumn 112, Issue 1, 2011, Pages 107-117

  Vaillancourt, France ^a   Silva, Patrick ^a   Shi, Qin ^a   Fahmi, Hassan ^a   Fernandes, Julio C ^a   Benderdour, Mohamed ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bone; Catabolism; Inflammation; Oxidative stress; Proliferation; Rheumatoid arthritis; Thymoquinone

Indexed keywords

4 HYDROXYNONENAL; ALKALINE PHOSPHATASE; COLLAGENASE 3; CYCLOOXYGENASE 2; DEUTERIUM OXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; THYMOQUINONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLACK CUMIN; BONE TURNOVER; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; TREATMENT RESPONSE; WESTERN BLOTTING;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; BENZOQUINONES; CELL PROLIFERATION; CYCLOOXYGENASE 2; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

NIGELLA SATIVA; RATTUS;

EID: 78651296775     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22884     Document Type: Article

References (50)

1. Alhosin M, Abusnina A, Achour M, Sharif T, Muller C, Peluso J, Chataigneau T, Lugnier C, Schini-Kerth VB, Bronner C, Fuhrmann G. 2010. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochem Pharmacol 79:1251-1260.
2. Ali BH, Blunden G. 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17:299-305.
3. Allen MJ. 2003. Biochemical markers of bone metabolism in animals: Uses and limitations. Vet Clin Pathol 32:101-113.
4. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M. 1986. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039-1049.
5. Bendele A. 2001. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 1:377-385.
6. Chabane N, Li X, Fahmi H. 2009. HDAC4 contributes to IL-1-induced mPGES-1 expression in human synovial fibroblasts through up-regulation of Egr-1 transcriptional activity. J Cell Biochem 106:453-463.
7. Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P. 2000. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12:1092-1099.
8. Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA. 2009. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 11:373-381.
9. Chen SH, Fahmi H, Shi Q, Benderdour M. 2010. Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein/5- lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes. Arthritis Res Ther 12:R21.
10. El Mezayen MR, El Gazzar GM, Nicolls MR, Marecki JC, Dreskin SC, Nomiyama H. 2006. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett 106:72-81.
11. El-Mahmoudy A, Shimizu Y, Shiina T, Matsuyama H, El-Sayed M, Takewaki T. 2005. Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism. Int Immunopharmacol 5:195-207.
12. El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, Schneider-Stock R, Gali-Muhtasib H. 2010. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 15:183-195.
13. Fernandes JC, Wang H, Jreyssaty C, Benderdour M, Lavigne P, Qiu X, Winnik FM, Zhang X, Dai K, Shi Q. 2008. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol Ther 16:1243-1251.
14. Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
15. Fye KH. 1999. New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs. Postgrad Med 106:82-90. 92.
16. Gali-Muhtasib H, Kuester D, Mawrin C, Bajbouj K, Diestel A, Ocker M, Habold C, Foltzer-Jourdainne C, Schoenfeld P, Peters B, ab-Assaf M, Pommrich U, Itani W, Lippert H, Roessner A, Schneider-Stock R. 2008. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res 68: 5609-5618.
17. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. 1998. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943-951.
18. Hammaker DR, Boyle DL, Inoue T, Firestein GS. 2007. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther 9:R57.
19. Houghton PJ, Zarka R, de las HB, Hoult JR. 1995. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61:33-36.
20. Ishida S, Yamane S, Nakano S, Yanagimoto T, Hanamoto Y, Maeda-Tanimura M, Toyosaki-Maeda T, Ishizaki J, Matsuo Y, Fukui N, Itoh T, Ochi T, Suzuki R. 2009. The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction. Immunology 128: E315-e324.
21. Ismail M, Al-Naqeep G, Chan KW. 2010. Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic Biol Med 48:664-672.
22. Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T, Yam LT. 2002. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clin Chim Acta 320:49-58.
23. Jungel A, Ospelt C, Lesch M, Thiel M, Sunyer T, Schorr O, Michel BA, Gay RE, Kolling C, Flory C, Gay S, Neidhart M. 2009. Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Ann Rheum Dis 69:898-902.
24. Kurien BT, Scofield RH. 2008. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7:567-573.
25. Ma MH, Kingsley GH, Scott DL. 2010. A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford) 49:91-98.
26. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA. 1996. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 39:583-591.
27. Morquette B, Shi Q, Lavigne P, Ranger P, Fernandes JC, Benderdour M. 2006. Production of lipid peroxidation products in osteoarthritic tissues: New evidence linking 4-hydroxynonenal to cartilage degradation. Arthritis Rheum 54:271-281.
28. O'Dell JR. 2004. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 350:2591-2602.
29. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
30. Pasupathi P, Deepa M, Rani P, Sankar RR. 2009. Circulating lipid peroxidation, plasma and erythrocyte antioxidant status in patients with rheumatoid arthritis. Bangladesh Med Res Counc Bull 35:57-62.
31. Polzer K, Baeten D, Soleiman A, Distler J, Gerlag DM, Tak PP, Schett G, Zwerina J. 2008. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis 67:1610-1616.
32. Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S, Shoker A. 2009. The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: A review. Saudi J Kidney Dis Transpl 20:741-752.
33. Ramprasath VR, Shanthi P, Sachdanandam P. 2006. Curative effect of Semecarpus anacardium Linn. Nut milk extract against adjuvant arthritis with special reference to bone metabolism. Chem Biol Interact 160:183-192.
34. Ravindran J, Nair HB, Sung B, Prasad S, Tekmal RR, Aggarwal BB. 2010. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochem Pharmacol 79:1640-1647.
35. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G. 2002. Osteoclasts are essential for TNFalpha- mediated joint destruction. J Clin Invest 110:1419-1427.
36. Remans PH, van OM, Smeets TJ, Sanders M, Frederiks WM, Reedquist KA, Tak PP, Breedveld FC, van Laar JM. 2005. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 52:2003-2009.
37. Salem ML. 2005. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 5:1749-1770.
38. Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G. 2000. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signalregulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 43:2501-2512.
39. Schett G, Stach C, Zwerina J, Voll R, Manger B. 2008. How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum 58:2936-2948.
40. Scott DL. 2000. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford) 39(Suppl 1): 24-29.
41. Sethi G, Ahn KS, Aggarwal BB. 2008. Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6:1059-1070.
42. Shi Q, Vaillancourt F, Cote V, Fahmi H, Lavigne P, Afif H, Di Battista JA, Fernandes JC, Benderdour M. 2006. Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal. Arthritis Res Ther 8:R159.
43. Tekeoglu I, Dogan A, Ediz L, Budancamanak M, Demirel A. 2007. Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res 21:895-897.
44. Torres MP, Ponnusamy MP, Chakraborty S, Smith LM, Das S, Arafat HA, Batra SK. 2010. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: Implications for the development of novel cancer therapies. Mol Cancer Ther 9:1419-1431.
45. Tsuboi H, Matsui Y, Hayashida K, Yamane S, Maeda-Tanimura M, Nampei A, Hashimoto J, Suzuki R, Yoshikawa H, Ochi T. 2003. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis 62:196-203.
46. Vaillancourt F, Fahmi H, Shi Q, Lavigne P, Ranger P, Fernandes JC, Benderdour M. 2008. 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: The protective role of glutathione-S-transferase. Arthritis Res Ther 10:R107.
47. Wang LY, Wang HY, Ouyang J, Yu L, Chen B, Qin JQ, Qiu XZ. 2009. Low concentration of lipopolysaccharide acts on MC3T3-E1 osteoblasts and induces proliferation via the COX-2-independent NFkappaB pathway. Cell Biochem Funct 27:238-242.
48. Williams RO. 2004. Collagen-induced arthritis as a model for rheumatoid arthritis. Methods Mol Med 98:207-216.
49. Xiao-Jun C, Min F, Liang C, Li L, Yuan-Yuan R, Xiao-Bo H, Rong W, Ming- Xiang Z, Yun Z, Mei Z. 2010. Expression and role of adiponectin receptor 1 in lipopolysaccharide-induced proliferation of cultured rat adventitial fibroblasts. Cell Biol Int 34:163-169.
50. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M. 2008. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 7:1789-1796.